Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.1.13ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.1.13ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.1.13ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.13NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
C.13ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
C.13ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
C.13ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
C.13NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
C.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
C.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
C.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.545ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.545ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.545ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.545NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.482ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.482ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.482ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.482NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HK.3.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HK.3.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.3.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.3.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GY.1.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GY.1.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GY.1.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GY.1.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HK.3.11ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HK.3.11ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.3.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.3.11NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JC.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JC.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JC.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JC.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.564ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.564ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.564ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.564NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.461ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.461ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.461ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.461NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.486ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.486ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.486ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.486NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used